Ver Investigador - - Prisma - Unidad de Bibliometría

Marina Rosa Pulido Toledano

Profesora Contratada Doctora
mpulido-ibis@us.es
Área de conocimiento: Microbiología
Departamento: Microbiología
Grupo: RESISTENCIA A ANTIMICROBIANOS - CTS-210 (Universidad de Sevilla)
Centro mixto: Instituto de Biomedicina de Sevilla (IBIS)

Investiga en

Tipo Año Título Fuente
Artículo2024 Genetic features of BEL-1-producing and KPC-2-producing E. coli from hospital wastewater: human source or sewages adaptation ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
Artículo2024 ginmappeR: an unified approach for integrating gene and protein identifiers across biological sequence databases Bioinformatics advances
Artículo2024 Heterogeneity of SOS response expression in clinical isolates of Escherichia coli influences adaptation to antimicrobial stress DRUG RESISTANCE UPDATES
Artículo2023 RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coli. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Artículo2023 Synergistic effect of SOS response and GATC methylome suppression on antibiotic stress survival in Escherichia coli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2022 Characterization of Extended-Spectrum β-Lactamase-Producing Shigella sonnei in Spain: Expanding the Geographic Distribution of Sequence Type 152/CTX-M-27 Clone ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2022 Identification of a Stable Chromosomal Tandem Multicopy of bla(VIM-63), a New bla(VIM-2) Carbapenemase JOURNAL OF BACTERIOLOGY
Artículo2020 A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection VACCINE
Artículo2018 Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia CLINICAL MICROBIOLOGY AND INFECTION
Artículo2018 Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection VACCINE
Artículo2018 Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii VIRULENCE
Artículo2017 High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems JOURNAL OF BIOLOGICAL CHEMISTRY
Póster2016 Effect of disinfectants used in clinical facilities on the induction of the SOS response and mutation frequency in Escherichia coli Biosaia
Revisión2016 Identifying targets for antibiotic development using omics technologies DRUG DISCOVERY TODAY
Artículo2016 Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Revisión2016 Vaccines for Antibiotic-Resistant Bacteria: Possibility or Pipe Dream? TRENDS IN PHARMACOLOGICAL SCIENCES
Póster2015 La inhibición de LpxC reduce la resistencia intrínseca de A. baumannii a diferentes clases de antibióticos Biosaia
Artículo2015 Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: study protocol for a randomized controlled trial TRIALS
Artículo2014 Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Póster2014 Búsqueda de nuevas dianas terapéuticas en Acinetobacter baumannii mediante la identificación de genes metabólicos implicados en la virulencia e infección Biosaia
Artículo2014 Immunization with Lipopolysaccharide-Deficient Whole Cells Provides Protective Immunity in an Experimental Mouse Model of Acinetobacter baumannii Infection PLOS ONE
Revisión2013 Emerging therapies for multidrug resistant Acinetobacter baumannii TRENDS IN MICROBIOLOGY
Artículo2013 First Steps Towards a Vaccine against Acinetobacter baumannii CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Artículo2013 Nutritional, hormonal, and depot-dependent regulation of the expression of the small GTPase Rab18 in rodent adipose tissue Journal of Molecular Endocrinology
Revisión2013 Progress on the development of rapid methods for antimicrobial susceptibility testing JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012 The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats Diabetes, Obesity and Metabolism
Artículo2012 The ghrelin O-acyltransferase-ghrelin system reduces TNF-alpha-induced apoptosis and autophagy in human visceral adipocytes DIABETOLOGIA
Artículo2012 The L-alpha-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity DIABETES
Artículo2011 Proteomic Profiling of Adipose Tissue from Zmpste24(-/-) Mice, a Model of Lipodystrophy and Premature Aging, Reveals Major Changes in Mitochondrial Function and Vimentin Processing MOLECULAR & CELLULAR PROTEOMICS
Artículo2011 Rab18 Dynamics in Adipocytes in Relation to Lipogenesis, Lipolysis and Obesity PLOS ONE
Ponencia2010 Mecanismos moleculares y celulares de la acción de RAB18 en adipocitos I Congreso Científico de Investigadores en Formación
Artículo2010 The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots PROTEOMICS
Artículo2009 Identification of Novel Genes Involved in the Plasticity of Pituitary Melanotropes in Amphibians ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Artículo2009 Resistin Regulates Pituitary Somatotrope Cell Function through the Activation of Multiple Signaling Pathways Endocrinology
Artículo2008 Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Mecanismos moleculares y celulares de la accion de rab18 en adipocitos (2010)
Dirigida por: Maria M. Malagón, Rafael Vázquez Martínez

Este investigador no ha dirigido/tutorizado tesis

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2022 31/05/2023 Responsable Estudio de la actividad antimicrobiana de cannabinoides y/o derivados frente bacterias gramnegativas multirresistentes prevalentes en Andalucía (US-1380820) Consejería de Economía, Conocimiento, Empresas y Universidad (Autonómico)
01/01/2021 31/12/2023 Investigador/a Procesos moleculares implicados en heteroresistance y tolerancia: estrategias de diagnóstico y eficacia antimicrobiana en clones multirresistentes de Enterobacterales. (Proyecto Tolerancia-Cero) (PI20/00239) Ministerio de Ciencia e Innovación (Instituto de Salud Carlos III) (Nacional)
01/09/2023 31/08/2026 Investigador/a Estudio del efecto de una bebida fermentada rica en péptidos bioactivos a partir de subproductos vegetales en los componentes principales del síndrome metabólico (PID2022-137792OB-I00) Ministerio de Ciencia e Innovación (Nacional)

Patentes

Nº Solicitud Fecha Solicitud Fecha Concesión Nombre
E14382164 05/05/2014 07/10/2020 Vacuna contra Acinetobacter baumannii basada en componentes celulares deficientes en lipopolisacárido